Avelumab in combination with lorlatinib or crizotinib in patients with previously treated advanced non-small cell lung cancer: phase 1b/2 results from the JAVELIN Lung 101 trial
JTO Clinical and Research Reports(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要